Vir Biotechnology (VIR) PT Raised to $10 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts VIR Hot Sheet
Price: $11.04 +4.45%
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 1
Rating Summary:
10 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 1
Join SI Premium – FREE
JPMorgan analyst Eric Joseph raised the price target on Vir Biotechnology (NASDAQ: VIR) to $10.00 (from $9.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Whitehaven Coal Ltd. (WHC:AU) (WHITF) PT Raised to AUD8.05 at UBS
- Metso OYJ (METSO:FH) (MXCYY) PT Raised to EUR15 at Barclays
- Hexagon AB (HEXAB:SS) (HXGBF) PT Raised to SEK105 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
